$ORGO Income Statement | Understand Stock

$ORGO

$0.90 -$0.03 (3.53%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue:
Net product revenue
Grant income
Total revenue
Cost of goods sold
Gross profit
Operating expenses:
Cost of goods sold
Selling, general and administrative
Research and development
Write-down to fair value for asset held for sale
Impairment of property and construction
Write-down of capitalized internal-use software costs
Total operating expenses
Income (loss) from operations
Other income (expense), net:
Gain on settlement of deferred acquisition consideration
Loss on the extinguishment of debt
Interest income (expense), net
Other income (expense), net
Total other income (expense), net

Net income (loss) before income taxes
Income tax benefit (expense)
Net income (loss) and comprehensive income (loss)
Accretion of redeemable convertible preferred stock to redemption value
Cumulative dividend on redeemable convertible preferred stock
Undistributed earnings allocated to participating redeemable convertible preferred stock
Net income (loss) attributable to common stockholders - basic
Net income (loss) attributable to common stockholders - diluted
Net income (loss) per share:
Basic
Diluted
Weighted-average common shares outstanding
Basic
Diluted

Comments